| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |